Horák Petr, Gibbons Nicholas, Sýkora Juraj, Batista Aida, Underhill Jonathan
University Hospital Motol, Hospital Pharmacy, Prague, Czech Republic.
Keele University, Centre for Medicines Optimisation School of Pharmacy Keele, Keele, UK.
Eur J Hosp Pharm. 2017 Sep;24(5):258-265. doi: 10.1136/ejhpharm-2017-001334. Epub 2017 Aug 9.
The 2016 European Association of Hospital Pharmacists (EAHP) Statements survey builds on previous surveys and focuses on sections 1, 3 and 4.
To collect statistical data about the level of implementation of the Statements, and identify important barriers to their implementation.
An online questionnaire was sent to all hospital pharmacies in EAHP member countries. Data were analysed by researchers from Keele University School of Pharmacy, UK and the EAHP Survey Group. If an incomplete survey was submitted, the quantitative data were not used, although any free-text responses were incorporated.
The overall response rate was 16% (904 out of 5711 requests) with 730 complete responses. In the first part of the survey, data were collected on the hospital pharmacy setting. While almost half (n=335) of hospital pharmacies served over 500 beds, 77% (n=564) of hospital pharmacies had ≤10 pharmacists. In section B, evidence was gathered about the degree of implementation of sections 1, 3 and 4 of the Statements and the main barriers to, and drivers of, implementation. The questions related to production and compounding (section 3) received very positive responses (all questions from this section received at least a 70% positive response rate), indicating that responders are having less difficulty implementing these statements compared with others. The introductory statements and governance questions (section 1) received a more mixed response. Only 343 (47%) responses indicated that the pharmacists worked routinely as part of multidisciplinary team. Many of the questions relating to clinical pharmacy services (section 4) received a more negative response overall, with six questions receiving <50% positive responses.
This iteration of the survey provides the EAHP with further insight into the implementation of the Statements across the member countries as well as the barriers to, and drivers of, implementation in sections 1, 3 and 4. This is essential to inform the plans for EAHP to best support their implementation.
2016年欧洲医院药师协会(EAHP)声明调查以之前的调查为基础,重点关注第1、3和4部分。
收集有关声明实施水平的统计数据,并确定实施过程中的重要障碍。
向EAHP成员国的所有医院药房发送在线问卷。数据由英国基尔大学药学院的研究人员和EAHP调查小组进行分析。如果提交的调查问卷不完整,则不使用定量数据,不过会纳入任何自由文本回复。
总体回复率为16%(5711份请求中有904份回复),其中730份为完整回复。在调查的第一部分,收集了有关医院药房环境的数据。虽然近一半(n = 335)的医院药房服务床位超过500张,但77%(n = 564)的医院药房药师人数≤10名。在B部分,收集了有关声明第1、3和4部分实施程度以及实施的主要障碍和推动因素的证据。与生产和配制(第3部分)相关的问题得到了非常积极的回复(该部分所有问题的积极回复率至少为70%),这表明与其他问题相比,受访者在实施这些声明方面遇到的困难较小。介绍性声明和治理问题(第1部分)的回复则较为参差不齐。只有343份(47%)回复表明药师作为多学科团队的一员定期开展工作。与临床药学服务相关的许多问题(第4部分)总体上得到了更负面的回复,有6个问题的积极回复率低于50%。
本次调查为EAHP提供了进一步了解声明在各成员国的实施情况以及第1、3和4部分实施的障碍和推动因素的机会。这对于为EAHP制定最佳支持声明实施的计划至关重要。